Literature DB >> 30524531

Myocardial infarction in a premenopausal woman with a decreased serum estrogen level due to leuprorelin acetate.

Takeshi Sasaki1, Toshio Kurosawa1, Hiroshi Yamaguchi2, Tomoyoshi Yanagisawa1, Akiyoshi Arikawa2, Hitoshi Takemura2, Yasuko Ikeda1, Tohru Izumi1.   

Abstract

A 45-year-old premenopausal woman was admitted with acute myocardial infarction. Her serum estrogen level was decreased because of leuprorelin acetate administration, 3 months prior to admission for the treatment of uterine myoma. Emergency coronary angiography revealed diffuse narrowing of the distal half of the left anterior descending artery (LAD). The second coronary angiography after anti-anginal medication revealed significant improvement in LAD narrowing, which suggested prolonged coronary vasospasm. She had no coronary risk factors except for a positive family history. This case suggests that a decreased serum estrogen level could cause ischemic heart disease even in premenopausal women.

Entities:  

Keywords:  Coronary vasospasm; Estrogen; Gender-related; Myocardial infarction; Pathophysiology; Risk factors

Year:  2010        PMID: 30524531      PMCID: PMC6264956          DOI: 10.1016/j.jccase.2009.12.009

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase.

Authors:  T Simoncini; A Hafezi-Moghadam; D P Brazil; K Ley; W W Chin; J K Liao
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

Review 2.  Estrogen and coronary heart disease in women.

Authors:  E Barrett-Connor; T L Bush
Journal:  JAMA       Date:  1991-04-10       Impact factor: 56.272

3.  Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy.

Authors:  D M Herrington; G A Braden; J K Williams; T M Morgan
Journal:  Am J Cardiol       Date:  1994-05-15       Impact factor: 2.778

4.  Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina.

Authors:  H Kawano; T Motoyama; M Ohgushi; K Kugiyama; H Ogawa; H Yasue
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

5.  Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina.

Authors:  H Kawano; T Motoyama; N Hirai; K Kugiyama; H Ogawa; H Yasue
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

6.  Angina and myocardial infarction with use of leuprolide acetate.

Authors:  M J McCoy
Journal:  Am J Obstet Gynecol       Date:  1994-07       Impact factor: 8.661

7.  Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry).

Authors:  F H Zimmerman; A Cameron; L D Fisher; G Ng
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

Review 8.  Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment.

Authors:  Hirofumi Yasue; Hitoshi Nakagawa; Teruhiko Itoh; Eisaku Harada; Yuji Mizuno
Journal:  J Cardiol       Date:  2008-02-01       Impact factor: 3.159

9.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Authors:  T L Bush; E Barrett-Connor; L D Cowan; M H Criqui; R B Wallace; C M Suchindran; H A Tyroler; B M Rifkind
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

10.  Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

Authors:  S E Reis; S T Gloth; R S Blumenthal; J R Resar; H A Zacur; G Gerstenblith; J A Brinker
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.